Endoluminal Suturing Devices

Global Endoluminal Suturing Devices Market to Reach US$106.8 Million by 2030

The global market for Endoluminal Suturing Devices estimated at US$71.4 Million in the year 2024, is expected to reach US$106.8 Million by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Bariatric Surgery, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$89.3 Million by the end of the analysis period. Growth in the Gastrointestinal Surgery segment is estimated at 9.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$19.5 Million While China is Forecast to Grow at 10.8% CAGR

The Endoluminal Suturing Devices market in the U.S. is estimated at US$19.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$22.2 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Endoluminal Suturing Devices Market – Key Trends & Drivers Summarized

Why Are Endoluminal Suturing Devices Transforming Minimally Invasive Surgery?

Endoluminal suturing devices are revolutionizing minimally invasive surgery (MIS) by enabling precise, internal suturing without the need for external incisions. These devices are widely used in gastrointestinal (GI) procedures, bariatric surgeries, gastroesophageal reflux disease (GERD) treatments, and endoscopic tissue approximation. The growing preference for endoscopic and laparoscopic surgeries over traditional open surgery has significantly boosted demand for advanced suturing technologies that enhance procedural accuracy and patient recovery.

The increasing prevalence of obesity and metabolic disorders has fueled the adoption of endoluminal bariatric procedures, such as endoscopic sleeve gastroplasty (ESG) and transoral gastric reduction techniques. Additionally, advancements in robotic-assisted suturing and AI-guided endoscopy have improved procedural outcomes, reducing the risk of complications such as post-operative leaks, perforations, and tissue trauma. As hospitals and surgical centers continue to invest in non-invasive therapeutic options, the market for endoluminal suturing devices is expected to expand significantly.

What Are the Latest Innovations in Endoluminal Suturing Devices?

The integration of robotics, AI, and real-time imaging has led to major breakthroughs in endoluminal suturing technology. Next-generation robotic suturing systems are enhancing precision and reducing human error, particularly in complex GI and bariatric surgeries. Innovations in self-tightening, biocompatible sutures have improved tissue healing and procedural durability, reducing the need for revision surgeries.

Additionally, AI-powered navigation systems and 3D imaging-assisted endoscopic suturing are increasing procedural success rates. The introduction of flexible and ergonomic suturing devices has further simplified transoral and transanal surgical interventions, making procedures more accessible for general surgeons and gastroenterologists. As the demand for scarless, incision-free surgical techniques continues to rise, manufacturers are focusing on developing ultra-precise, automated suturing tools for a variety of endoscopic applications.

What Is Driving the Growth of the Endoluminal Suturing Devices Market?

The growth in the endoluminal suturing devices market is driven by rising obesity rates, increased demand for minimally invasive surgical procedures, and technological advancements in endoscopic instrumentation. The surge in bariatric procedures, particularly non-surgical weight loss interventions, has contributed significantly to market expansion. Additionally, rising healthcare expenditures, improved endoscopy training programs, and growing acceptance of robotic-assisted endoluminal procedures have boosted adoption rates.

The emergence of AI-driven surgical planning, biodegradable sutures, and next-generation suturing robotics is expected to further revolutionize the market. Additionally, increasing FDA and EU approvals for novel endoluminal devices, along with the expansion of outpatient and ambulatory surgical centers (ASCs), is making these procedures more accessible and cost-effective. As medical professionals and patients increasingly opt for scarless, minimally invasive alternatives, the endoluminal suturing device market is poised for continued growth.

SCOPE OF STUDY:

The report analyzes the Endoluminal Suturing Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Application (Bariatric Surgery, Gastrointestinal Surgery, Gastresophageal Reflux Surgery, Others); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Apollo Endosurgery, Inc.
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Cook Group Incorporated
• Endo Tools Therapeutics S.A.
• ErgoSuture
• Johnson & Johnson (Ethicon)
• Karl Storz SE & Co. KG
• LSI Solutions, Inc.
• Medtronic plc
• Mellon Medical B.V.
• Nitinotes Surgical
• Olympus Corporation
• Ovesco Endoscopy AG
• Richard Wolf GmbH
• Smith & Nephew plc
• Sutrue Ltd.
• Teleflex Incorporated
• Terumo Corporation
• USGI Medical

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.